DocGo Inc. (DCGO)
NASDAQ: DCGO · IEX Real-Time Price · USD
3.090
-0.120 (-3.74%)
At close: Jul 19, 2024, 4:00 PM
3.120
+0.030 (0.97%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
DocGo Revenue
DocGo had revenue of $703.37M in the twelve months ending March 31, 2024, with 61.46% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $192.09M with 69.98% year-over-year growth. In the year 2023, DocGo had annual revenue of $624.29M with 41.72% growth.
Revenue (ttm)
$703.37M
Revenue Growth
+61.46%
P/S Ratio
0.45
Revenue / Employee
$168,918
Employees
4,164
Market Cap
313.84M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 624.29M | 183.77M | 41.72% |
Dec 31, 2022 | 440.52M | 121.80M | 38.21% |
Dec 31, 2021 | 318.72M | 224.63M | 238.74% |
Dec 31, 2020 | 94.09M | 45.79M | 94.81% |
Dec 31, 2019 | 48.30M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
OraSure Technologies | 304.64M |
Amarin Corporation | 277.46M |
Aurora Cannabis | 253.96M |
Zynex | 188.68M |
Sutro Biopharma | 154.07M |
Scilex Holding Company | 47.05M |
MacroGenics | 43.36M |
Nyxoah | 5.57M |
DCGO News
- 2 days ago - DocGo Inc Is Under Investigation By The Schall Law Firm And Affected Investors Are Encouraged To Start Dialogue - Accesswire
- 3 days ago - The Schall Law Firm Is Investigating DocGo Inc And Urges Impacted Investors To Initiate Conversations - Accesswire
- 4 days ago - DocGo Inc Is Under Examination By The Schall Law Firm, Investors Who Have Been Affected Are Encouraged To Start Dialogues - Accesswire
- 5 days ago - The Schall Law Firm Urges Affected Investors To Initiate Conversation, DocGo Inc Is Under Scrutiny - Accesswire
- 6 days ago - DocGo Inc Under Investigation By The Schall Law Firm Encouraging Impacted Investors To Start Dialogue - Accesswire
- 6 days ago - OQ Chemicals Launches Biomass-Balanced OxBalance Neopentyl Glycol Diheptanoate for Cosmetics - Business Wire
- 7 days ago - Ambulnz by DocGo Launches Emergency Medical Services in Dover, Delaware - Business Wire
- 8 days ago - The Schall Law Firm Starts Probe Into DocGo Inc And Urges Affected Investors To Initiate Conversation - Accesswire